Product
AZD0186
1 clinical trial
1 indication
Indication
Type 2 DiabetesClinical trial
A Phase 1 Randomized, Single-blind, Placebo-controlled, First-in-Human and Sequential Group Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186 Following Single Ascending Doses Via Oral AdministrationStatus: Terminated, Estimated PCD: 2023-05-10